↓ Skip to main content

Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece

Overview of attention for article published in BMC Health Services Research, September 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter
2 X users
patent
1 patent

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
76 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece
Published in
BMC Health Services Research, September 2014
DOI 10.1186/1472-6963-14-419
Pubmed ID
Authors

Charalampos Tzanetakos, Andreas Melidonis, Christos Verras, Georgia Kourlaba, Nikos Maniadakis

Abstract

To evaluate the long-term cost-effectiveness of liraglutide versus sitagliptin or exenatide, added to oral antidiabetic drug mono- or combination therapy respectively, in patients with Type 2 diabetes in Greece.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 22%
Researcher 13 17%
Student > Bachelor 8 11%
Student > Ph. D. Student 5 7%
Other 4 5%
Other 10 13%
Unknown 19 25%
Readers by discipline Count As %
Medicine and Dentistry 22 29%
Economics, Econometrics and Finance 14 18%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Social Sciences 3 4%
Nursing and Health Professions 2 3%
Other 7 9%
Unknown 23 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2017.
All research outputs
#6,136,648
of 22,764,165 outputs
Outputs from BMC Health Services Research
#2,877
of 7,618 outputs
Outputs of similar age
#64,092
of 251,438 outputs
Outputs of similar age from BMC Health Services Research
#50
of 142 outputs
Altmetric has tracked 22,764,165 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 7,618 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 251,438 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 142 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.